Reuters logo
BRIEF-U.S. FDA expands approved use of Dexcom's G5 mobile continuous glucose monitoring system
December 20, 2016 / 7:55 PM / 9 months ago

BRIEF-U.S. FDA expands approved use of Dexcom's G5 mobile continuous glucose monitoring system

Dec 20 (Reuters) - U.S. Food and Drug Administration

* The u.s. Fda expands approved use of dexcom’s g5 mobile continuous glucose monitoring system

* u.s. Fda - fda expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below